High-acuity vision depends on the developmental establishment of specialized retinal regions. How disruption of the transcriptional programs that direct retinal regionalization contributes to human visual disorders remains incompletely understood. Bosch-Boonstra-Schaaf optic atrophy syndrome (BBSOAS), caused by pathogenic variants in NR2F1, is characterized by visual impairment and offers a human genetic entry point to investigate mechanisms that couple transcriptional regulation to retinal specialization.
The source study used mouse models and human data to test whether NR2F1 controls molecular networks that pattern the retina and whether disruption of those networks can explain structural retinal abnormalities in BBSOAS patients.
The investigators employed three complementary Nr2f1 mouse models, including two that carry patient-specific mutations, and applied single-cell RNA sequencing to characterize transcriptional changes associated with Nr2f1 loss or mutation. The single-cell strategy enabled cell type–resolved identification of Nr2f1-dependent gene expression programs across retinal cell populations.
Details on sequencing depth, number of cells, exact time points, or specific cell clustering metrics were reported in the original preprint but are not reproduced here; readers should consult the source for full methodological parameters.
Across the three Nr2f1 mouse models, the authors identified a shared transcriptional signature that depends on Nr2f1 function and is enriched for genes involved in the retinoic acid (RA) pathway. The convergence of changes across models, including patient-specific alleles, supports that this RA-associated program is a core component of NR2F1 activity in the developing retina.
The characterization positioned RA signaling as a downstream axis influenced by NR2F1, implicating local RA availability and metabolism in the establishment of retinal regional identity.
Loss or mutation of Nr2f1 disrupted the spatial organization of RA pathway components within the retina. The most prominent change was expansion of the dorso-equatorial expression domain of Cyp26a1 into more ventral retinal territories. Cyp26a1 encodes an enzyme that catabolizes retinoic acid, so its altered distribution implies changes in local RA gradients.
Concomitant with the expanded Cyp26a1 domain, the authors observed reductions in ventral identity markers such as Vax2. Together, these molecular alterations indicate that NR2F1 is required to maintain the normal dorso–ventral patterning of RA signaling and transcriptional determinants in the developing retina.
The molecular patterning changes were associated with an altered dorso–ventral distribution of cone photoreceptors expressing S- and M-opsins. In other words, shifts in RA signaling and ventral identity markers correlated with redistribution of cone subtype markers that underlie regional specializations of the retina important for color and acuity functions.
The source links these photoreceptor distribution changes mechanistically to the NR2F1-dependent regulation of the RA pathway and its spatial configuration across the retina.
Complementing the mouse transcriptional data, the authors provide evidence that human NR2F1 binds a conserved regulatory region upstream of CYP26A1, supporting a direct transcriptional role for NR2F1 in controlling local RA catabolism. This molecular interaction offers a mechanistic path from NR2F1 genomic activity to modulation of RA availability in retinal tissue.
Specific binding assays, chromatin contexts, and sequence details were presented in the preprint; consult the primary source for experimental particulars.
To test whether NR2F1-dependent retinal patterning defects have clinical correlates, the investigators performed high-resolution optical coherence tomography (OCT) in individuals with BBSOAS. OCT imaging revealed reproducible foveal abnormalities across affected individuals: a smaller and shallower foveal pit and increased central retinal thickness. These structural features are consistent with foveal hypoplasia.
The presence of these reproducible OCT findings supports a retina-intrinsic contribution to the visual deficits observed in BBSOAS, rather than effects limited to optic nerve or post-retinal pathways alone.
The combined mouse genetic, single-cell transcriptomic, regulatory binding, and human imaging data define an NR2F1–RA/CYP26A1 regulatory axis that is necessary for proper dorso–ventral retinal regionalization and cone photoreceptor distribution. Disruption of this axis by pathogenic NR2F1 variants provides a plausible retina-intrinsic mechanism for visual impairment in BBSOAS and specifically reveals foveal hypoplasia as a consistent structural phenotype in patients.
These findings expand the pathogenic model of BBSOAS to include defects in retinal specialization driven by altered local retinoic acid signaling, and they prioritize RA pathway components and CYP26A1 regulation as potential mechanistic targets for further study.
This work is reported as a preprint and has not undergone peer review. The present summary reports the major findings and interpretations as stated in the source article; specific experimental datasets, quantitative results, and methodological details are available in the original preprint and supplementary materials but are not reproduced exhaustively here.